JWK001
/ Genevector Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2026
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
(clinicaltrials.gov)
- P2 | N=50 | Recruiting | Sponsor: West China Hospital
New P2 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1